These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 9412407)

  • 21. [Ultrastructure of the spores of fungal strains, producers of fusidic acid, varying in antibiotic activity].
    Bartoshevich IuE; Zaslavskaia PL; Beliaeva TV
    Antibiotiki; 1983 Aug; 28(8):563-6. PubMed ID: 6685451
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis of an antibiotic closely resembling fusidic acid by imperfect and perfect Dermatophytes.
    Elander RP; Gordee RS; Wilgus RM; Gale RM
    J Antibiot (Tokyo); 1969 Apr; 22(4):176-8. PubMed ID: 5800428
    [No Abstract]   [Full Text] [Related]  

  • 23. [The effect of dimethyl-(imidazol-1-yl) methanesulfonic acid on experimental atherogenesis in rabbits].
    Dautova GS; Kosykh VA; Repin VS; Kamburg RA
    Eksp Klin Farmakol; 1994; 57(5):21-4. PubMed ID: 7696897
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Characteristics of the oxidative metabolism in strains with varying levels of fucidin biosynthesis].
    Gol'dshteĭn VL; Torbochkina LI; Bartoshevich IuE
    Antibiotiki; 1975 Apr; 20(4):333-9. PubMed ID: 2097
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Selection of natural variants, biological properties, preparation of inoculum of the producent of fusidin and method of determination of antibiotic activity].
    Kuznetsov VD; Suprun TP; Smirnova AD; Pivovarova EV; Melekhova NP
    Antibiotiki; 1967 Jan; 12(1):13-7. PubMed ID: 4968829
    [No Abstract]   [Full Text] [Related]  

  • 26. [Carbohydrate and pyruvic acid degradation pathways in Fusidium coccineum strains with varying levels of antibiotic synthesis].
    Gol'dshteĭn VL; Mironov VA; Bartoshevich IuE; Minina TS
    Antibiotiki; 1976 Oct; 21(10):887-92. PubMed ID: 11736
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Species differences in the inhibiting effect of fluvastatin, a new inhibitor of HMG-CoA reductase, on cholesterol biosynthesis.
    Yamamoto A; Itoh S; Hoshi K; Ichihara K
    Res Commun Mol Pathol Pharmacol; 1994 Dec; 86(3):325-34. PubMed ID: 7712108
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A cholesterol biosynthesis inhibitor from Rhizopus oryzae.
    Kim HJ; Yim SH; Lee IS
    Arch Pharm Res; 2004 Jun; 27(6):624-7. PubMed ID: 15283464
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The pharmacologic elegance of inhibiting cholesterol absorption and synthesis while providing a homeostatic balance.
    Catapano AL
    Fundam Clin Pharmacol; 2007 Nov; 21 Suppl 2():21-6. PubMed ID: 18001316
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of policosanol on the hepatic cholesterol biosynthesis of normocholesterolemic rats.
    Menendez R; Amor AM; Gonzalez RM; Fraga V; Mas R
    Biol Res; 1996; 29(2):253-7. PubMed ID: 9278716
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Newer hypolipidemic agents.
    Kritchevsky D
    Fed Proc; 1971; 30(3):835-40. PubMed ID: 4996475
    [No Abstract]   [Full Text] [Related]  

  • 32. [New treatment option for decreasing blood cholesterol level--clinical significance of inhibition of both, cholesterol absorption and synthesis].
    Paragh G; Márk L; Czine Z
    Orv Hetil; 2004 Apr; 145(15):805-11. PubMed ID: 15188635
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Uncovering the repertoire of fungal secondary metabolites: From Fleming's laboratory to the International Space Station.
    Boruta T
    Bioengineered; 2018 Jan; 9(1):12-16. PubMed ID: 28632991
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effects on lipid metabolism of inhibitors of cholesterol synthesis].
    Guarini G; Costa C; Trimarco C; Santese D; Vitaliano E
    Clin Ter; 1988 Apr; 125(1):41-50. PubMed ID: 2974357
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of D-003, a mixture of long-chain aliphatic primary acids, fluvastatin and the combined therapy of D-003 plus fluvastatin on the lipid profile of normocholesterolemic rabbits.
    Mendoza S; Gamez R; Mas R; Goicochea E
    Int J Tissue React; 2003; 25(3):81-9. PubMed ID: 14756189
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypolipidemic activity of some derivatives of 6H-dibenzo[b,d]pyran.
    Banzatti C; Branzoli U; Lovisolo PP; Melloni P; Orsini G; Salvadori P
    Arzneimittelforschung; 1984; 34(8):864-9. PubMed ID: 6541922
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Microbial models in screening of inhibitors of sterol biosynthesis].
    Trenin AS
    Antibiot Khimioter; 2013; 58(7-8):3-11. PubMed ID: 24757827
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anticholesterolemic effect of 3,4-di(OH)-phenylpropionic amides in high-cholesterol fed rats.
    Kim SJ; Bok SH; Lee S; Kim HJ; Lee MK; Park YB; Choi MS
    Toxicol Appl Pharmacol; 2005 Oct; 208(1):29-36. PubMed ID: 16164959
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and hypocholesterolemic activities of eritadenine derivatives.
    Okumura K; Matsumoto K; Fukamizu M; Yasuo H; Taguchi Y
    J Med Chem; 1974 Aug; 17(8):846-55. PubMed ID: 4845378
    [No Abstract]   [Full Text] [Related]  

  • 40. [Screening of natural immunosuppressors by their ability to modify steroid synthesis in hepatocytes].
    Bibikova MV; Grammatikova NE; Tertov VV; Pinegin BV; Chmel' IaV; Katlinskiĭ AV
    Antibiot Khimioter; 2003; 48(8):3-6. PubMed ID: 14722935
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.